Literature DB >> 19340622

Is aromatase expression in the endometrium the cause of endometriosis and related infertility?

Hugo Maia1, Julio Casoy, Jorge Valente Filho.   

Abstract

Aromatase expression in the endometrium seems to play a pivotal role in the development of endometriotic lesions. Because inflammatory mediators such as prostaglandin E2 appear to activate aromatase in the cells of the endometrial stroma, it was hypothesised that the ensuing inflammation caused by the arrival of aromatase-positive cells in the peritoneal cavity would stimulate local estrogen production, which would in turn facilitate the development of endometriotic lesions by suppressing macrophage phagocytosis. Aromatase expression in the eutopic endometrium will also hamper ovum nidation, thus causing infertility. Progestins, such as gestodene and danazol, are potent inhibitors of aromatase expression in the endometrium, and the use of vaginal rings with danazol in doses that do not block ovulation is associated with the occurrence of pregnancy in patients with severe endometriosis without the need for surgery. A local effect on the endometrium suppressing aromatase expression has been suggested as a possible mechanism of action for the danazol ring.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340622     DOI: 10.1080/09513590802627647

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  10 in total

Review 1.  Tissue physiology and pathology of aromatase.

Authors:  Carlos Stocco
Journal:  Steroids       Date:  2011-11-13       Impact factor: 2.668

2.  Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue.

Authors:  Wanwisa Waiyaput; Keerati Wattanakamolchai; Yada Tingthanatikul; Srithean Lertvikool; Siriluk Tantanavipas; Kanthanadon Dittharot; Morakot Sroyraya; Areepan Sophonsritsuk
Journal:  J Ovarian Res       Date:  2021-05-12       Impact factor: 4.234

3.  Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis.

Authors:  Hugo Maia; Clarice Haddad; Julio Casoy
Journal:  Int J Womens Health       Date:  2012-02-23

4.  Effect of a hormone-releasing intrauterine system (Mirena(®)) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection.

Authors:  Hugo Maia; Clarice Haddad; Julio Casoy; Rebeca Maia; Nathanael Pinheiro; Elsimar M Coutinho
Journal:  Int J Womens Health       Date:  2012-04-12

5.  CYFRA 21-1 in urine: a diagnostic marker for endometriosis?

Authors:  Risto Gjavotchanoff
Journal:  Int J Womens Health       Date:  2015-02-09

6.  LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis.

Authors:  Jing Guo; Li Chen; Ning Luo; Caixia Li; Rong Chen; Xiaoyan Qu; Mingmin Liu; Le Kang; Zhongping Cheng
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

Review 7.  Cyclooxygenase-2 in Endometriosis.

Authors:  Zhen-Zhen Lai; Hui-Li Yang; Si-Yao Ha; Kai-Kai Chang; Jie Mei; We-Jie Zhou; Xue-Min Qiu; Xiao-Qiu Wang; Rui Zhu; Da-Jin Li; Ming-Qing Li
Journal:  Int J Biol Sci       Date:  2019-10-23       Impact factor: 6.580

8.  Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain.

Authors:  Hugo Maia; Clarice Haddad; Nathanael Pinheiro; Julio Casoy
Journal:  Int J Womens Health       Date:  2012-10-10

9.  The effect of oral contraceptives on aromatase and Cox-2 expression in the endometrium of patients with idiopathic menorrhagia or adenomyosis.

Authors:  Hugo Maia; Clarice Haddad; Nathaniel Pinheiro; Julio Casoy
Journal:  Int J Womens Health       Date:  2013-06-13

10.  CYP19 gene variant confers susceptibility to endometriosis-associated infertility in Chinese women.

Authors:  Ledan Wang; Xiaosheng Lu; Danhan Wang; Wanglei Qu; Wenju Li; Xiaowen Xu; Qiusui Huang; Xueying Han; Jieqiang Lv
Journal:  Exp Mol Med       Date:  2014-06-27       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.